RM Medical Research Inc

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia2 trials
• Atopic dermatitis (eczema)1 trial
• Coronary artery disease1 trial
• Stroke1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Escient Pharmaceuticals, Inc1 trial

Running trials

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

  NCT06144424· Phase 2· Escient Pharmaceuticals, Inc· Source